KDM6A and acute myeloid leukemia: UTX is a key tumor suppressor with a strong phase-separating ability, and its IDR-lacking mutant eliminated condensation and resulted in the loss or gain of long-range chromatin loops in the acute myeloid leukemia (AML) cell line (Shi et al. 2021).